| Amgen negotiates 2 large anemia drug contracts with DaVita and Fresenius. |
|
| LA Times: Amgen Inc., aiming to secure future sales of its flagship anemia drug Epogen as potential competition emerges, has reached new supply contracts with the two largest operators of U.S. kidney dialysis clinics. |